Top compounds associated with response to RP13-582O9.6


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0004
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.09 0.004
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.007
mRNA ML050 CTRPv2 pan-cancer AAC 0.099 0.008
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.087 0.008
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.008
mRNA Merck60 CTRPv2 pan-cancer AAC -0.079 0.008
Download CSV